← Patent-cliff monitor small molecule PYRUKYND MITAPIVAT SULFATE
Loss of exclusivity July 2041 latest FDA-listed patent expiry
Drug detail Brand name PYRUKYND Active ingredient MITAPIVAT SULFATE Strength EQ 20MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval February 2022 Marketing status RX
Listed patents Patent Expires Type 11878049 July 2041 use U-3782 11254652 November 2038 substance, product 11234976 October 2038 use U-3321 RE49582 April 2035 substance, product 11793806 April 2033 use U-3320 9193701 October 2032 use U-3319 10632114 May 2032 use U-3320 9682080 May 2032 use U-3319 9980961 May 2032 use U-3319
Regulatory exclusivity Code Expires ODE-392 February 2029 NCE February 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.